Form 8.3 - International Paper Company

LONDON--()-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13-11-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

6,623,892

1.90

(2) Cash-settled derivatives: 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

10,400

0.003

7,900

0.002

TOTAL:

10,400

0.003

6,631,792

1.90

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

19

56.34

Common Stock

Sale

21

56.84

Common Stock

Sale

25

56.29

Common Stock

Sale

37

56.71

Common Stock

Sale

40

56.58

Common Stock

Sale

41

56.45

Common Stock

Sale

43

56.32

Common Stock

Sale

49

56.77

Common Stock

Sale

50

56.60

Common Stock

Sale

50

56.66

Common Stock

Sale

56

56.50

Common Stock

Sale

58

56.39

Common Stock

Sale

61

56.55

Common Stock

Sale

63

56.42

Common Stock

Sale

89

56.38

Common Stock

Sale

127

56.87

Common Stock

Sale

141

56.57

Common Stock

Sale

198

56.41

Common Stock

Sale

200

56.30

Common Stock

Sale

244

56.25

Common Stock

Sale

885

56.33

Common Stock

Purchase

3

56.45

Common Stock

Purchase

5

56.15

Common Stock

Purchase

13

56.70

Common Stock

Purchase

18

56.83

Common Stock

Purchase

18

56.93

Common Stock

Purchase

30

55.91

Common Stock

Purchase

30

56.34

Common Stock

Purchase

39

56.37

Common Stock

Purchase

40

56.29

Common Stock

Purchase

44

56.18

Common Stock

Purchase

50

56.73

Common Stock

Purchase

52

56.97

Common Stock

Purchase

55

56.66

Common Stock

Purchase

60

56.34

Common Stock

Purchase

65

56.63

Common Stock

Purchase

77

56.68

Common Stock

Purchase

90

56.35

Common Stock

Purchase

90

56.97

Common Stock

Purchase

94

56.33

Common Stock

Purchase

100

56.05

Common Stock

Purchase

100

56.23

Common Stock

Purchase

100

56.27

Common Stock

Purchase

100

56.41

Common Stock

Purchase

100

56.59

Common Stock

Purchase

100

56.60

Common Stock

Purchase

100

56.61

Common Stock

Purchase

100

56.72

Common Stock

Purchase

100

56.75

Common Stock

Purchase

100

56.90

Common Stock

Purchase

103

56.96

Common Stock

Purchase

111

55.98

Common Stock

Purchase

134

56.37

Common Stock

Purchase

136

56.48

Common Stock

Purchase

147

56.56

Common Stock

Purchase

149

55.93

Common Stock

Purchase

199

56.23

Common Stock

Purchase

200

56.01

Common Stock

Purchase

200

56.05

Common Stock

Purchase

200

56.16

Common Stock

Purchase

200

56.91

Common Stock

Purchase

220

56.62

Common Stock

Purchase

221

56.58

Common Stock

Purchase

227

56.30

Common Stock

Purchase

227

56.81

Common Stock

Purchase

228

56.03

Common Stock

Purchase

228

56.94

Common Stock

Purchase

258

56.50

Common Stock

Purchase

262

56.51

Common Stock

Purchase

264

56.50

Common Stock

Purchase

286

56.76

Common Stock

Purchase

290

56.08

Common Stock

Purchase

296

56.62

Common Stock

Purchase

308

56.00

Common Stock

Purchase

310

55.97

Common Stock

Purchase

316

56.18

Common Stock

Purchase

332

56.86

Common Stock

Purchase

338

56.79

Common Stock

Purchase

339

56.85

Common Stock

Purchase

342

56.54

Common Stock

Purchase

358

56.04

Common Stock

Purchase

362

56.70

Common Stock

Purchase

365

56.54

Common Stock

Purchase

368

56.95

Common Stock

Purchase

372

56.77

Common Stock

Purchase

374

56.02

Common Stock

Purchase

393

56.69

Common Stock

Purchase

400

56.64

Common Stock

Purchase

421

56.42

Common Stock

Purchase

422

55.95

Common Stock

Purchase

444

56.05

Common Stock

Purchase

456

56.44

Common Stock

Purchase

459

56.41

Common Stock

Purchase

460

56.16

Common Stock

Purchase

481

56.34

Common Stock

Purchase

486

56.87

Common Stock

Purchase

572

56.67

Common Stock

Purchase

582

55.99

Common Stock

Purchase

631

56.14

Common Stock

Purchase

636

56.55

Common Stock

Purchase

656

56.43

Common Stock

Purchase

673

55.94

Common Stock

Purchase

686

56.17

Common Stock

Purchase

708

56.46

Common Stock

Purchase

734

56.91

Common Stock

Purchase

752

56.82

Common Stock

Purchase

764

56.93

Common Stock

Purchase

777

56.78

Common Stock

Purchase

806

56.13

Common Stock

Purchase

821

56.57

Common Stock

Purchase

853

56.83

Common Stock

Purchase

892

56.09

Common Stock

Purchase

917

56.84

Common Stock

Purchase

943

56.06

Common Stock

Purchase

943

56.36

Common Stock

Purchase

954

56.59

Common Stock

Purchase

969

56.45

Common Stock

Purchase

985

56.53

Common Stock

Purchase

1014

56.92

Common Stock

Purchase

1017

56.52

Common Stock

Purchase

1021

56.71

Common Stock

Purchase

1030

56.89

Common Stock

Purchase

1038

56.19

Common Stock

Purchase

1058

56.56

Common Stock

Purchase

1093

56.27

Common Stock

Purchase

1133

56.47

Common Stock

Purchase

1162

56.48

Common Stock

Purchase

1183

56.44

Common Stock

Purchase

1231

56.33

Common Stock

Purchase

1264

56.21

Common Stock

Purchase

1267

56.72

Common Stock

Purchase

1275

56.20

Common Stock

Purchase

1302

56.74

Common Stock

Purchase

1368

56.80

Common Stock

Purchase

1379

56.50

Common Stock

Purchase

1385

56.11

Common Stock

Purchase

1394

56.90

Common Stock

Purchase

1517

56.04

Common Stock

Purchase

1552

56.61

Common Stock

Purchase

1574

56.08

Common Stock

Purchase

1584

56.35

Common Stock

Purchase

1669

56.12

Common Stock

Purchase

1706

56.40

Common Stock

Purchase

1708

56.65

Common Stock

Purchase

1794

56.51

Common Stock

Purchase

1818

56.24

Common Stock

Purchase

1825

56.49

Common Stock

Purchase

1850

56.07

Common Stock

Purchase

1906

56.39

Common Stock

Purchase

1920

56.88

Common Stock

Purchase

1925

56.60

Common Stock

Purchase

2033

56.37

Common Stock

Purchase

2067

56.73

Common Stock

Purchase

2067

56.75

Common Stock

Purchase

2377

56.32

Common Stock

Purchase

2379

56.28

Common Stock

Purchase

2444

56.23

Common Stock

Purchase

2504

56.22

Common Stock

Purchase

3319

55.96

Common Stock

Purchase

3397

56.26

Common Stock

Purchase

3516

56.25

Common Stock

Purchase

3825

56.31

Common Stock

Purchase

4372

56.30

Common Stock

Purchase

4705

56.29

Common Stock

Purchase

5128

56.10

Common Stock

Purchase

52510

56.38

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

14-11-2024

Contact name:

Janice Falcao

Telephone number:

00442033140679

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Call option IP US 04/17/25 C47.5 Equity

Purchase

1,000

USD 47.5

American

04/17/25

Common Stock

Call option IP US 01/17/25 C47.5 Equity

Purchase

200

USD 47.5

American

01/17/25

Common Stock

Put option IP US 04/17/25 P45 Equity

Written

300

USD 45

American

04/17/25

Common Stock

Call option IP US 06/20/25 C50 Equity

Purchase

300

USD 50

American

06/20/25

Common Stock

Call option IP US 10/17/25 C55 Equity

Purchase

500

USD 55

American

10/17/25

Common Stock

Call option IP US 06/20/25 C52.5 Equity

Purchase

2,000

USD 52.5

American

06/20/25

Common Stock

Put option IP US 12/20/24 P57.5 Equity

Purchase

3,200

USD 57.5

American

12/20/24

Common Stock

Put option IP US 01/17/25 P47.5 Equity

Written

400

USD 47.5

American

01/17/25

Common Stock

Call option IP US 09/19/25 C42.5 Equity

Purchase

600

USD 42.5

American

09/19/25

Common Stock

Put option IP US 04/17/25 P47.5 Equity

Written

2,400

USD 47.5

American

04/17/25

Common Stock

Call option IP US 01/16/26 C60 Equity

Purchase

300

USD 60

American

01/16/26

Common Stock

Call option IP US 10/17/25 C42.5 Equity

Purchase

700

USD 42.5

American

10/17/25

Common Stock

Call option IP US 01/16/26 C50 Equity

Purchase

500

USD 50

American

01/16/26

Common Stock

Call option IP US 12/20/24 C50 Equity

Purchase

300

USD 50

American

12/20/24

Common Stock

Call option IP US 01/17/25 C60 Equity

Written

200

USD 60

American

01/17/25

Common Stock

Call option IP US 04/17/25 C50 Equity

Purchase

200

USD 50

American

04/17/25

Common Stock

Call option IP US 04/17/25 C52.5 Equity

Purchase

600

USD 52.5

American

04/17/25

Common Stock

Put option IP US 01/16/26 P42.5 Equity

Written

4,600

USD 42.5

American

01/16/26

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

Category Code: RET
Sequence Number: 1260467
Time of Receipt (offset from UTC): 20241114T111225+0000

Contacts

Qube Research & Technologies LTD

Contacts

Qube Research & Technologies LTD